Literature DB >> 17167064

CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity.

Daniela Drenkard1, Florian M Becke, Joachim Langstein, Thilo Spruss, Leoni A Kunz-Schughart, Teng Ee Tan, Yaw Chyn Lim, Herbert Schwarz.   

Abstract

The cytokine receptor CD137 is a member of the TNF receptor family and a potent T cell costimulatory molecule. Its ligand is expressed on antigen presenting cells as a transmembrane protein and it too can deliver signals into the cells it is expressed on (reverse signaling). In monocytes, immobilized CD137 protein induces activation, prolongation of survival and proliferation. Here we show that recombinant immobilized CD137 protein enhances migration of monocytes in vitro. Further, CD137 expression on spheroids leads to a significantly enhanced infiltration by monocytes. The migration-inducing activity of CD137 could be confirmed in vivo. Matrigel, which was coated with recombinant CD137 protein and was inserted into the flanks of mice attracted large numbers of monocytes and was heavily infiltrated by these cells. In vivo, expression of CD137 by blood vessel walls at sites of inflammation was detectable by immunohistochemistry. CD137 expression is inducible by proinflammatory cytokines in endothelial cells, suggesting that a physiological function of CD137 may be the facilitation of monocyte extravasation in inflammatory tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17167064     DOI: 10.1096/fj.05-4739com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  48 in total

1.  The process of macrophage migration promotes matrix metalloproteinase-independent invasion by tumor cells.

Authors:  Romain Guiet; Emeline Van Goethem; Céline Cougoule; Stéphanie Balor; Annie Valette; Talal Al Saati; Clifford A Lowell; Véronique Le Cabec; Isabelle Maridonneau-Parini
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

2.  Tumor necrosis factor receptor subfamily 9 (Tnfrsf9) gene is expressed in distinct cell populations in mouse uterus and conceptus during implantation period of pregnancy.

Authors:  Kirsten Eckstrum; Brent M Bany
Journal:  Cell Tissue Res       Date:  2011-05-12       Impact factor: 5.249

Review 3.  Development of CAR T cells designed to improve antitumor efficacy and safety.

Authors:  Janneke E Jaspers; Renier J Brentjens
Journal:  Pharmacol Ther       Date:  2017-03-22       Impact factor: 12.310

Review 4.  CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses.

Authors:  Bhushan Dharmadhikari; Meihui Wu; Nur Sharalyn Abdullah; Sakthi Rajendran; Nur Diana Ishak; Emily Nickles; Zulkarnain Harfuddin; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2015-11-11       Impact factor: 8.110

5.  Development of experimental autoimmune encephalomyelitis critically depends on CD137 ligand signaling.

Authors:  Julia M Martínez Gómez; J Ludovic Croxford; Kim Pin Yeo; Véronique Angeli; Herbert Schwarz; Stephan Gasser
Journal:  J Neurosci       Date:  2012-12-12       Impact factor: 6.167

6.  CD137 is required for M cell functional maturation but not lineage commitment.

Authors:  En Hui Hsieh; Xiomara Fernandez; Jing Wang; Mary Hamer; Stephanie Calvillo; Michael Croft; Byoung S Kwon; David D Lo
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

7.  Suppression of Tie-1 in endothelial cells in vitro induces a change in the genome-wide expression profile reflecting an inflammatory function.

Authors:  Barden Chan; Vikas P Sukhatme
Journal:  FEBS Lett       Date:  2009-02-21       Impact factor: 4.124

8.  CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.

Authors:  Matthew W Anderson; Shuchun Zhao; Aharon G Freud; Debra K Czerwinski; Holbrook Kohrt; Ash A Alizadeh; Roch Houot; Denize Azambuja; Irene Biasoli; José Carlos Morais; Nelson Spector; Hernan F Molina-Kirsch; Roger A Warnke; Ronald Levy; Yasodha Natkunam
Journal:  Am J Pathol       Date:  2012-09       Impact factor: 4.307

9.  Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling.

Authors:  Charles Gullo; Liang Kai Koh; Wan Lu Pang; Kian Tong Ho; Shi Hao Tan; Herbert Schwarz
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

10.  CD137-CD137 Ligand Interactions in Inflammation.

Authors:  Byungsuk Kwon
Journal:  Immune Netw       Date:  2009-06-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.